目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Application
Exhibit 06: Executive Summary - Chart on Market Segmentation by Type
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size
4.1 Global sjogrens syndrome therapeutics market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on global sjogrens syndrome therapeutics market 2017 - 2021 ($ million)
4.2 Application Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Application
6.1 Market segments
Exhibit 30: Chart on Application - Market share 2022-2027 (%)
Exhibit 31: Data Table on Application - Market share 2022-2027 (%)
6.2 Comparison by Application
Exhibit 32: Chart on Comparison by Application
Exhibit 33: Data Table on Comparison by Application
6.3 Clinical - Market size and forecast 2022-2027
Exhibit 34: Chart on Clinical - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Clinical - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Clinical - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Clinical - Year-over-year growth 2022-2027 (%)
6.4 Hospital - Market size and forecast 2022-2027
Exhibit 38: Chart on Hospital - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Hospital - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Application
Exhibit 42: Market opportunity by Application ($ million)
Exhibit 43: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by Type
7.1 Market segments
Exhibit 44: Chart on Type - Market share 2022-2027 (%)
Exhibit 45: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 46: Chart on Comparison by Type
Exhibit 47: Data Table on Comparison by Type
7.3 Primary - Market size and forecast 2022-2027
Exhibit 48: Chart on Primary - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Data Table on Primary - Market size and forecast 2022-2027 ($ million)
Exhibit 50: Chart on Primary - Year-over-year growth 2022-2027 (%)
Exhibit 51: Data Table on Primary - Year-over-year growth 2022-2027 (%)
7.4 Secondary - Market size and forecast 2022-2027
Exhibit 52: Chart on Secondary - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Secondary - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Secondary - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Secondary - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Type
Exhibit 56: Market opportunity by Type ($ million)
Exhibit 57: Data Table on Market opportunity by Type ($ million)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 Germany - Market size and forecast 2022-2027
Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.9 China - Market size and forecast 2022-2027
Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)
9.10 Japan - Market size and forecast 2022-2027
Exhibit 91: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 ADVANZ PHARMA Corp.
Exhibit 107: ADVANZ PHARMA Corp. - Overview
Exhibit 108: ADVANZ PHARMA Corp. - Business segments
Exhibit 109: ADVANZ PHARMA Corp. - Key offerings
Exhibit 110: ADVANZ PHARMA Corp. - Segment focus
12.4 Bristol Myers Squibb Co.
Exhibit 111: Bristol Myers Squibb Co. - Overview
Exhibit 112: Bristol Myers Squibb Co. - Product / Service
Exhibit 113: Bristol Myers Squibb Co. - Key news
Exhibit 114: Bristol Myers Squibb Co. - Key offerings
12.5 Daiichi Sankyo Co. Ltd.
Exhibit 115: Daiichi Sankyo Co. Ltd. - Overview
Exhibit 116: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibit 117: Daiichi Sankyo Co. Ltd. - Key news
Exhibit 118: Daiichi Sankyo Co. Ltd. - Key offerings
12.6 GlaxoSmithKline Plc
Exhibit 119: GlaxoSmithKline Plc - Overview
Exhibit 120: GlaxoSmithKline Plc - Business segments
Exhibit 121: GlaxoSmithKline Plc - Key news
Exhibit 122: GlaxoSmithKline Plc - Key offerings
Exhibit 123: GlaxoSmithKline Plc - Segment focus
12.7 Hikma Pharmaceuticals Plc
Exhibit 124: Hikma Pharmaceuticals Plc - Overview
Exhibit 125: Hikma Pharmaceuticals Plc - Business segments
Exhibit 126: Hikma Pharmaceuticals Plc - Key offerings
Exhibit 127: Hikma Pharmaceuticals Plc - Segment focus
12.8 Horizon Therapeutics Plc
Exhibit 128: Horizon Therapeutics Plc - Overview
Exhibit 129: Horizon Therapeutics Plc - Business segments
Exhibit 130: Horizon Therapeutics Plc - Key news
Exhibit 131: Horizon Therapeutics Plc - Key offerings
Exhibit 132: Horizon Therapeutics Plc - Segment focus
12.9 Johnson and Johnson
Exhibit 133: Johnson and Johnson - Overview
Exhibit 134: Johnson and Johnson - Business segments
Exhibit 135: Johnson and Johnson - Key news
Exhibit 136: Johnson and Johnson - Key offerings
Exhibit 137: Johnson and Johnson - Segment focus
12.10 MorphoSys AG
Exhibit 138: MorphoSys AG - Overview
Exhibit 139: MorphoSys AG - Product / Service
Exhibit 140: MorphoSys AG - Key offerings
12.11 Novartis AG
Exhibit 141: Novartis AG - Overview
Exhibit 142: Novartis AG - Business segments
Exhibit 143: Novartis AG - Key offerings
Exhibit 144: Novartis AG - Segment focus
12.12 Otsuka Holdings Co. Ltd.
Exhibit 145: Otsuka Holdings Co. Ltd. - Overview
Exhibit 146: Otsuka Holdings Co. Ltd. - Business segments
Exhibit 147: Otsuka Holdings Co. Ltd. - Key offerings
Exhibit 148: Otsuka Holdings Co. Ltd. - Segment focus
12.13 RemeGen Ltd.
Exhibit 149: RemeGen Ltd. - Overview
Exhibit 150: RemeGen Ltd. - Product / Service
Exhibit 151: RemeGen Ltd. - Key offerings
12.14 Resolve Therapeutics LLC
Exhibit 152: Resolve Therapeutics LLC - Overview
Exhibit 153: Resolve Therapeutics LLC - Product / Service
Exhibit 154: Resolve Therapeutics LLC - Key offerings
12.15 TearSolutions Inc.
Exhibit 155: TearSolutions Inc. - Overview
Exhibit 156: TearSolutions Inc. - Product / Service
Exhibit 157: TearSolutions Inc. - Key offerings

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 158: Inclusions checklist
Exhibit 159: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 160: Currency conversion rates for US$
13.4 Research methodology
Exhibit 161: Research methodology
Exhibit 162: Validation techniques employed for market sizing
Exhibit 163: Information sources
13.5 List of abbreviations
Exhibit 164: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Application
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on global sjogrens syndrome therapeutics market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Type Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Application - Market share 2022-2027 (%)
Exhibits31: Data Table on Application - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Application
Exhibits33: Data Table on Comparison by Application
Exhibits34: Chart on Clinical - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Clinical - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Clinical - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Clinical - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Hospital - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Hospital - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Hospital - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Hospital - Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Application ($ million)
Exhibits43: Data Table on Market opportunity by Application ($ million)
Exhibits44: Chart on Type - Market share 2022-2027 (%)
Exhibits45: Data Table on Type - Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Type
Exhibits47: Data Table on Comparison by Type
Exhibits48: Chart on Primary - Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Primary - Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Primary - Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Primary - Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Secondary - Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Secondary - Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Secondary - Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Secondary - Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Type ($ million)
Exhibits57: Data Table on Market opportunity by Type ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: ADVANZ PHARMA Corp. - Overview
Exhibits108: ADVANZ PHARMA Corp. - Business segments
Exhibits109: ADVANZ PHARMA Corp. - Key offerings
Exhibits110: ADVANZ PHARMA Corp. - Segment focus
Exhibits111: Bristol Myers Squibb Co. - Overview
Exhibits112: Bristol Myers Squibb Co. - Product / Service
Exhibits113: Bristol Myers Squibb Co. - Key news
Exhibits114: Bristol Myers Squibb Co. - Key offerings
Exhibits115: Daiichi Sankyo Co. Ltd. - Overview
Exhibits116: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits117: Daiichi Sankyo Co. Ltd. - Key news
Exhibits118: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits119: GlaxoSmithKline Plc - Overview
Exhibits120: GlaxoSmithKline Plc - Business segments
Exhibits121: GlaxoSmithKline Plc - Key news
Exhibits122: GlaxoSmithKline Plc - Key offerings
Exhibits123: GlaxoSmithKline Plc - Segment focus
Exhibits124: Hikma Pharmaceuticals Plc - Overview
Exhibits125: Hikma Pharmaceuticals Plc - Business segments
Exhibits126: Hikma Pharmaceuticals Plc - Key offerings
Exhibits127: Hikma Pharmaceuticals Plc - Segment focus
Exhibits128: Horizon Therapeutics Plc - Overview
Exhibits129: Horizon Therapeutics Plc - Business segments
Exhibits130: Horizon Therapeutics Plc - Key news
Exhibits131: Horizon Therapeutics Plc - Key offerings
Exhibits132: Horizon Therapeutics Plc - Segment focus
Exhibits133: Johnson and Johnson - Overview
Exhibits134: Johnson and Johnson - Business segments
Exhibits135: Johnson and Johnson - Key news
Exhibits136: Johnson and Johnson - Key offerings
Exhibits137: Johnson and Johnson - Segment focus
Exhibits138: MorphoSys AG - Overview
Exhibits139: MorphoSys AG - Product / Service
Exhibits140: MorphoSys AG - Key offerings
Exhibits141: Novartis AG - Overview
Exhibits142: Novartis AG - Business segments
Exhibits143: Novartis AG - Key offerings
Exhibits144: Novartis AG - Segment focus
Exhibits145: Otsuka Holdings Co. Ltd. - Overview
Exhibits146: Otsuka Holdings Co. Ltd. - Business segments
Exhibits147: Otsuka Holdings Co. Ltd. - Key offerings
Exhibits148: Otsuka Holdings Co. Ltd. - Segment focus
Exhibits149: RemeGen Ltd. - Overview
Exhibits150: RemeGen Ltd. - Product / Service
Exhibits151: RemeGen Ltd. - Key offerings
Exhibits152: Resolve Therapeutics LLC - Overview
Exhibits153: Resolve Therapeutics LLC - Product / Service
Exhibits154: Resolve Therapeutics LLC - Key offerings
Exhibits155: TearSolutions Inc. - Overview
Exhibits156: TearSolutions Inc. - Product / Service
Exhibits157: TearSolutions Inc. - Key offerings
Exhibits158: Inclusions checklist
Exhibits159: Exclusions checklist
Exhibits160: Currency conversion rates for US$
Exhibits161: Research methodology
Exhibits162: Validation techniques employed for market sizing
Exhibits163: Information sources
Exhibits164: List of abbreviations